GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway
Every year, hundreds of thousands of patients with colorectal cancer are placed on a drug combination that oncology has trusted ...
Every year, hundreds of thousands of patients with colorectal cancer are placed on a drug combination that oncology has trusted ...
Gastric cancer remains one of the world’s most lethal malignancies, and its treatment is increasingly threatened by resistance to cisplatin, ...
Head and neck squamous cell carcinoma (HNSCC) is among the world’s most challenging cancers, accounting for approximately 90% of malignancies ...
Glioblastoma (GBM) is an aggressive brain cancer that frequently returns after treatment, largely due to acquired resistance to standard chemotherapy ...
A groundbreaking epigenetic therapy has emerged as a promising contender against some of the most treatment-resistant forms of acute myeloid ...
Glioblastoma, the most aggressive and fatal form of brain cancer, has long posed a formidable challenge due to its notorious ...
In a groundbreaking development that could redefine the treatment landscape for multiple myeloma, teclistamab, a novel bispecific antibody, has demonstrated ...
In the ongoing battle against ovarian cancer, a formidable challenge has persisted: a subset of these tumors exhibits an uncanny ...
In the relentless battle against pediatric brain tumors, a beacon of hope emerges from the laboratories of the Medical University ...
A groundbreaking advancement in cancer treatment has emerged from a collaborative preclinical study conducted by renowned Spanish research institutions, the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine